-
1
-
2
-
1
-
2
Clearpol's Opinion of this Guidance as of 05/02/2008
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's Summary of this Guidance

The California Department of Health has issued an All Facilities Letter regarding the recall of Heparin products due to reported adverse reactions in patients. These reactions include acute hypotension and anaphylactic type reactions. The contamination of raw materials used to produce the products is believed to be the cause of these reactions. Healthcare facilities, including nursing homes, are requested to review all drug storage areas and ensure that all recalled Heparin has been removed and is no longer available for patient use. The manufacturers involved in the recall are Baxter International, B. Braun, American Health Packaging (AHP), and Covidien. Facilities can obtain a list of affected products and lot numbers from their suppliers or the FDA website. Compliance with this recall is essential to ensure patient safety and avoid potential consequences for non-compliance.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
You have 0 new tasks available
Below are AI generated tasks related to this document. Accept or deny a task.
Task | Deadline | Actions |
---|
No suggested tasks available at the moment!
AI generated tasks related to this document are shown here. Tasks may be coming soon or you may have accepted/denied all the available tasks for this document.
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.